Clinical studies indicate that the presence and higher titers of anti-IFN-γ autoantibodies correlate significantly with severe or critical COVID-19 cases, suggesting their potential role as biomarkers for predicting disease severity [45]. The gene discussed is IFNG; the disease is COVID-19.